Abstract:Objective\r\nIt is well known that the suppression of gastric acidity is one of the most essential factors in promoting healing and preventing relapse of peptic ulcers. Little is known, however, about how to inhibit gastric acid secretion effectively in children with peptic ulcers. The present study aimed at understanding the optimal acid suppression by examining the relationship between ulcer healing and the suppression of gastric acid in children.\r\n\r\n\r\nMethods\r\nPatients with peptic ulcers diagnosed by endoscopy were randomized to receive either oral ranitidine (group A) or oral omeprazole (group B) for 4-6 weeks (mean 5 weeks) . Intragastric 24-hour pH monitoring was performed before treatment, and repeated three times: on day 1, weeks 1 and 5 post-dosing. Endoscopy was repeated on week 5 to evaluate the healing condition of ulcers.\r\n\r\n\r\nResults\r\nTwenty-seven patients followed up by endoscopy and pH monitoring were eligible for final analysis. The ulcers in 16 patients of group A and in all (11 cases) of group B were healed. No significant differences in the gastric mean pH, median pH and percentage of time with gastric pH \u003e 3 between the two groups were observed before treatment. Gastric pH increased significantly after treatment in both groups. These parameters in group A decreased significantly during weeks 1 and 5 as compared to those on day 1 post-dosing; the duration of drug action was also shortened significantly. The gastric mean pH and mean median pH in group B were significantly higher during weeks 1 and 5than on day 1 of post-dosing, the duration of drug action was also prolonged significantly. According to the result of endoscopic re-examination, the authors subdivided group A into unhealed (group C) and healed (group D) groups. The gastric acid suppressive effect in group C attenuated significantly by the end of the 5-week treatment and the differences of gastric mean pH and median pH, percentage of time with pH \u003e 3 between week 5 and pre-treatment level were not significant. While these parameters in group D were still significantly higher during week 5than those obtained before treatment. The gastric mean pH and median pH, percentage of time with pH \u003e 3 and the duration of drug action during week 5 were significantly higher in group D than in group C. The mean shortest duration of drug action in group B was 10 h, while it was 5 h in group D.\r\n\r\n\r\nConclusions\r\nThe onset of tolerance to ranitidine during the therapy might have affected healing of ulcers in the subjects. The optimal acid suppression for healing ulcere in children could be regarded as maintaining the gastric pH \u003e 3 for 5-10 hours a day of post-dosing during 4-6 weeks of anti-secretory treatment.\r\n\r\n\r\nKey words: \r\nPeptic ulcer; Hydrogen-ion concentration; Ranitidine; Omeprazole; Drug tolerance

The Evolution of Anti-Ulcer Therapy with Cimetidine. Is a Single Large Nocturnal Dose of Cimetidine the Right Therapy for Duodenal Ulcer?

Effect of cimetidine treatment in the prevention of gastric ulcer relapse: a one year double blind multicentre study.

Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease

Short term treatment of gastric ulcer: a comparison of sucralfate and cimetidine.

Optimal suppression of gastric acid and ulcer healing in children with peptic ulcer

Maintenance therapy: a two year comparison between Caved-S and cimetidine treatment in the prevention of symptomatic gastric ulcer recurrence.

[The differentiated treatment of patients with duodenal peptic ulcer]

Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer.

Verification of decreased basal and stimulated serum pepsinogen-I levels is a useful non-invasive method for determining the success of eradication therapy for Helicobacter pylori

Duodenal and antral mucosal prostaglandin E2 synthesis in a study of normal subjects and all stages of duodenal ulcer disease treated by H2 receptor antagonists.

Efficacy and safety of proton pump inhibitors and H2 receptor antagonists in the initial non‑eradication treatment of duodenal ulcer: A network meta‑analysis

[Ranitidine and cimetidine in the prevention of stress: ulcer hemorrhage a prospective comparative multicenter study]

Three-day Lansoprazole Quadruple Therapy for Helicobacter Pylori Positive Duodanal Ulcers: A Randomized Controlled Study

One-Day Quadruple Therapy Compared With 7-Day Triple Therapy for Helicobacter pylori Infection

Is Short-Term Therapy Really Sufficient to Eradicate Helicobacter Pylori Infection?

Acid-suppressive Effects of Rabeprazole: Comparing 10mg and 20mg Twice Daily in Japanese Helicobacter Pylori-Negative and -Positive CYP2C19 Extensive Metabolisers

One-Week Antibiotics versus Maintenance Acid Suppression Therapy for Helicobacter pylori-Associated Peptic Ulcer Bleeding

Evolution of Helicobacter pylori therapy from a meta-analytical perspective

Night-time intra-oesophageal bile and acid: a comparison between gastro-oesophageal reflux disease patients who failed and those who were treated successfully with a proton pump inhibitor

A Non-Inferiority Study: Modified Dual Therapy Consisting Higher Doses of Rabeprazole Is as Successful as Standard Quadruple Therapy in Eradication of Helicobacter pylori

The Use of H 2 ‐Receptor Antagonist in the Treatment of Peptic Ulcer Disease in Children